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In this issue ofNeuron, Ma et al. (2014) show that long-term depression of two independent prefrontal cortical
inputs to nucleus accumbens modifies behavioral responses controlling incubation of cocaine craving.
Intriguingly, one input increases while the other attenuates behavioral responses, hinting that both ‘‘prore-
lapse’’ and ‘‘antirelapse’’ pathways are strengthened after cocaine self-administration.If treating addiction were as simple as
separating the user from the drug, we
would be able to treat and cure substance
use disorders. Instead, as anyone who
has ever tried to quit can tell you, the
quitting is not the hardest part, despite
the acute symptoms of physical depen-
dence—instead, it’s the constant nagging
cravings that develop during abstinence
and that, for many, increase rather than
diminishing with time (Gawin and Kleber,
1986). Drug-related environmental cues
can exacerbate this, seemingly acting as
triggers of craving. How can we under-
stand the escalation of drug craving that
occurs during withdrawal?
One attractive rodent model of this
escalation process has been called
incubation of craving (Pickens et al.,
2011). Rats are trained to self-administer
cocaine in a specific environment and
then withdrawn from the drug entirely for
different periods of time. Reintroducing
the animal to the same environment and
cues even without any cocaine results indrug-seeking behavioral responses, i.e.,
a lever press or nose poke that previ-
ously delivered cocaine. Remarkably,
the operant responding (despite no drug
delivery) increases markedly, as much as
3-fold, from day 1 to day 90 after with-
drawal from the original cocaine (Pickens
et al., 2011). These behavioral responses
appear to reflect the gradually escalating
craving for cocaine developing during
withdrawal, measured by the willingness
of the rat to work to seek the drug.
Synaptic strength and number are
widely viewed as essential building blocks
by which the nervous system remodels
during development, learning, and myriad
environmental conditions and stimuli,
including exposure to and self-adminis-
tration of addictive drugs (Lu¨scher and
Malenka, 2011). The paper by Ma et al.
(2014) in this issue has identified
novel opposing cocaine-induced synap-
tic modifications during the incubation of
cocaine craving in specific prefrontal
cortical (PFC) inputs to the nucleus ac-cumbens (NAc), a brain region essential
for the development of addiction in both
human patients and animal models. The
authors first confirmed earlier anatomical
work showing that two prefrontal cortical
regions, the infralimbic cortex (IL) and
the prelimbic cortex (PrL), provide major
glutamatergic inputs to the shell (Sh) and
core (Co) of the NAc, respectively. The
authors then virally delivered channelrho-
dopsin into the IL or PrL, allowing them
later to use light pulses to stimulate selec-
tively glutamatergic synapses arising from
either injected brain region. They allowed
rats to self-administer cocaine over a
7 day period and then examined func-
tional properties of each pathway in NAc
slices prepared at 1 or 45 days after
withdrawal. They first measured silent
synapses, synapses at which glutamate
is released but postsynaptic sites contain
NMDARs, but no AMPARs, and thus are
functionally silent at resting membrane
potentials (Kerchner and Nicoll, 2008).
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NMDAR CI-AMPARCP-AMPAR
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Figure 1. Synaptic Changes during Incubation of Craving
Diagram of two glutamatergic synapses in the nucleus accumbens before
cocaine exposure and at two withdrawal time points during the incubation
of cocaine craving.
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Previewsthe IL-to-shell or PrL-to-core
pathway at 1 day of with-
drawal from cocaine, Ma and
colleagues found that the per-
centage of silent synapses
had increased greatly in both
pathways. By 45 days of with-
drawal, however, in both re-
gions the percentage of silent
synapses had returned to
basal values. By the addition
of AMPARs, synapses can
become unsilenced, as hap-
pens for example during
NMDAR-dependent LTP, cir-
cuit development, and some
forms of homeostatic synap-
tic scaling (Lee, 2012; Hanse
et al., 2013). Previous work
had indicated that a key
component of incubation of
cocaine craving is the inser-
tion of GluA2-lacking, Ca2+-
permeable AMPARs (CP-AM-
PARs; Loweth et al., 2014).Did the unsilencing of NAc synapses
result from insertion of CP-AMPARs?
Nothing so simple: Ma and colleagues
discovered at 45 days of withdrawal that
while the IL-to-shell synapses did indeed
have increased levels of CP-AMPARs,
the PrL-to-core synapses did not,
becoming unsilenced by inclusion of the
far more common Ca2+-impermeable
AMPARs (CI-AMPARs). Thus, at the time
when animals exhibited 2-fold greater
cocaine seeking than on withdrawal day
1, previously silent synapses had become
functional via the insertion of AMPARs.
Might this synaptic remodeling be
responsible for the increased behavioral
responding that characterizes incubation
of craving? And if so, could this process
be reversed?
Inmany brain regions, different forms of
long-term synaptic depression (LTD) are
mediated by the removal of AMPARs,
and synapses in the NAc can exhibit
different forms of LTD (Malenka and
Bear, 2004; Lu¨scher and Huber, 2010).
Again using light stimulation of each opto-
genetically labeled pathway, Ma and col-
leagues next tested whether LTD could
be induced in the IL-to-shell or the
PrL-to-core pathways in brain slices from
rats exhibiting incubation of craving.
They found that LTD could be induced in
both pathways, successfully removingeither the CI-AMPARs (PrL-to-core) or
CP-AMPARs (IL-to-shell) present at with-
drawal day 45. Presumably as a conse-
quence of this removal, the percentage
of silent synapses in each pathway was
also increased. Importantly for the in vivo
experiment to come, the protocol chosen
for LTD induction had little effect on syn-
aptic strength in animals that only
received saline during the behavioral ex-
periments, suggesting that fully estab-
lished synapses remained unaffected by
the LTD protocol.
The optogenetic approach provides a
powerful way to forge links between
in vitro experiments investigating a spe-
cific brain circuit and in vivo behavioral
experiments in which the same circuit is
manipulated. Here, Ma et al. used this
approach to test the hypothesis that resil-
encing the synapses in one or both of the
PFC-to-NAc pathways would reverse the
incubation of cocaine craving observed
behaviorally. When PrL-to-core synapses
were resilenced using the optogenetic
LTD protocol, animals sharply reduced
their nose-poking responses—they ap-
peared to have lost the incubation of
craving. Surprisingly, the IL-to-shell syn-
apses may play an opposing role: when
these synapses were resilenced after
LTD, the rats considerably increased their
nose-poking response, as if resilencingNeuron 83, September 17,these synapses removed a
brake on the incubation of
craving. Together these ex-
periments show that cocaine
self-administration rapidly in-
creases the percentage of
silent glutamatergic syn-
apses in the NAc and that
synaptic maturation charac-
terized by either CP-AMPAR
or CI-AMPAR synapses is
apparent after several weeks
(Figure 1). LTD protocols
used to reverse the matura-
tion process significantly alter
behavioral consequences in
the incubation of craving
model of relapse.
Silent synapses are promi-
nent early in development,
but diminish during adult-
hood. Their reappearance in
the more mature nervous sys-
tem could be considered as
the reopening of a plasticperiod, enabling adaptation to a new set
of conditions. What explains the prolifera-
tion of synapses after taking cocaine?
One likely hypothesis is that a form of ho-
meostatic plasticity is initiated, as occurs
in response to functional deprivation.
Perhaps during repeated cocaine admin-
istration the excitability of NAc medium
spiny neurons is reduced sufficiently
to drive reactive formation of new synap-
ses. Previous work demonstrated that
repeated exposure to cocaine or amphet-
amine markedly increased dendritic
branch number and density of dendritic
spines (sites of glutamatergic synapses)
on NAc medium spiny neurons (Robinson
and Kolb, 2004), suggesting that function-
ally silent synapses seen on withdrawal
day 1 could be nascent synapses,
perhaps located on newly formed den-
dritic spines. During withdrawal, these
silent synapses can then be unsilenced,
perhaps representing a more mature syn-
aptic condition. The insertion of AMPARs,
especially CP-AMPARs, is a recurring
adaptation reported in several different
brain regions in response to environ-
mental changes. For example, CP-
AMPARs increase in the hippocampus
after ischemia (Liu and Zukin, 2007), in
the lateral amygdala after fear condition-
ing (Clem and Huganir, 2010), in the visual
cortex upon dark rearing (Lee 2012), and2014 ª2014 Elsevier Inc. 1235
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Previewsin the NAc after cocaine self-administra-
tion (Lu¨scher and Malenka, 2011; Loweth
et al., 2014; Ma et al., 2014). CI-AMPARs
and CP-AMPARs have different channel
conductances, andmodulation by endog-
enous polyamines provides short-term
plasticity properties to CP-AMPAR syn-
apses absent in CI-AMPAR synapses.
Moreover, allowing intracellular Ca2+
through synaptic CP-AMPAR channels
without the checks and balances that
restrict Ca2+ entry through NMDARs or
voltage-gated Ca2+ channels risks
unhealthy levels of intracellular Ca2+ dur-
ing ordinary neurotransmission, or may
drive plastic changes at the affected input
to the exclusion of other inputs (Liu and
Zukin, 2007). Whether these dire predic-
tions occur following insertion of CP-AM-
PARs at IL-to-shell synapses and whether
CP-AMPARs remain at these synapses
indefinitely remains to be tested.
Only one of the two pathways exam-
ined in this study developed unsilenced
synapses via inclusion of CP-AMPARs,
while the other utilized more common
CI-AMPARs. As demonstrated in the
NAc by Ma et al., it is possible to remove
new AMPARs of either type using an
LTD protocol. Perhaps most important in
the context of drug craving is the fate of
resilenced synapses after undergoing
LTD. Ma et al. induced LTD immediately
prior to the final drug-seeking behavior
session. For how long do these synapses
now remain silent? Is this functional
silencing a transient condition? During
NMDAR-dependent LTD (such as occurs
in the PrL-to-core synapses), NMDARs
as well as AMPARs can be removed,
and this overall weakening of the synapse
may presage synapse elimination (Hanse
et al., 2013). The LTD protocol does
not necessarily ‘‘reset’’ synapses in the
PFC-to-NAc pathways to the cocaine-
naive state, but to the state at the begin-
ning of withdrawal, i.e., there is still
an increased number of silent synapses
relative to those in a drug-naive animal.
The duration of in vivo LTD in these
accumbens synapses and its behavioral1236 Neuron 83, September 17, 2014 ª2014outcomes on cocaine-seeking represent
important future directions. Rats trained
to self-administer other addictive sub-
stances such as heroin, alcohol, nicotine,
and even sucrose also exhibit incubation
of craving, suggesting that this phenome-
non is a general mechanism induced by
withdrawal from highly motivating stimuli
(Pickens et al., 2011). It will be interesting
to see if a similar reversible remodeling of
synapses in these PFC-to-NAc pathways
also regulates incubation of craving for
these other substances.
The NAc is innervated bymultiple excit-
atory afferents beyond the prefrontal cor-
tex, including the basolateral amygdala,
hippocampus, and thalamus. Intriguing
complementary studies utilizing optoge-
netics indicate clearly that activation of
perhaps all of these inputs contributes to
motivated behavior (Britt et al., 2012),
and even to the incubation of craving
(Leeet al., 2013); however, all of thepieces
do not yet fit neatly together.We are still at
a stage where our understanding of this
fascinating and complex circuit is reminis-
cent of the blind man and the elephant.
While it will be some time before we can
fit all the information together to provide
a coherent view of how the NAc generates
and controls motivated behavior, this
piecemeal approach is absolutely essen-
tial in these early days todevelop a catalog
linking region-specific and cell-type-
specific drive with behavior.
Cocaine is well known to induce prore-
lapse or proaddictive neuroadaptations
in multiple brain regions. By discovering
the existence of cocaine-triggered adap-
tations in the IL-to-shell that form a novel
endogenous ‘‘antirelapse’’ mechanism,
the study by Ma et al. suggests impor-
tant new synaptic and circuit-level tar-
gets for intervening to reduce drug
craving. In the rodent model of incuba-
tion of craving, the magnitude of re-
sponding is influenced by a variety of
factors, including environmental enrich-
ment, age, exercise, and the estrus
cycle, and we speculate that selective in-
teractions with environmental/hormonalElsevier Inc.factors could preferentially modulate
synapses in one of the two prefrontal
cortex-to-NAc pathways (Pickens et al.,
2011). Genetic or environmentally altered
differences in the two PFC-to-NAc cir-
cuits or their relative activity levels could
contribute to an individual’s relative sus-
ceptibility to substance abuse disorders,
and the mechanistic understanding pro-
vided by Ma and colleagues of how
these important ‘‘antirelapse’’ synapses
can be strengthened might be used to
treat cocaine craving.
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